Charles N York Ii Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity

Charles N York Ii is COO and CFO of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 294,715 shares of DAWN, which is worth approximately $2.59 Million. The most recent transaction as insider was on Feb 17, 2023, when has been sold 9,377 shares (Common Stock) at a price of $20.03 per share, resulting in proceeds of $187,821. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 295K

6.01% 3M change

22.73% 12M change

Total Value Held $2.59 Million

Charles N York II Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 17 2023	SELL Open market or private sale	$187,821 $20.03 p/Share	9,377 Reduced 3.45%	262,128 Common Stock
Feb 16 2023	SELL Open market or private sale	$18,200 $19.57 p/Share	930 Reduced 0.34%	271,505 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	-	3,625 Added 1.31%	272,435 Common Stock
Jan 20 2023	SELL Open market or private sale	$227,500 $22.75 p/Share	10,000 Reduced 3.59%	268,810 Common Stock
Dec 20 2022	SELL Open market or private sale	$200,700 $20.07 p/Share	10,000 Reduced 3.49%	276,497 Common Stock
Nov 21 2022	SELL Open market or private sale	$210,700 $21.07 p/Share	10,000 Reduced 3.37%	286,497 Common Stock
Nov 16 2022	SELL Open market or private sale	$9,227 $21.46 p/Share	430 Reduced 0.14%	296,497 Common Stock

Nov 15 2022	BUY Exercise of conversion of derivative security	-	1,375 Added 0.46%	295,776 Common Stock
Nov 01 2022	SELL Open market or private sale	$200,300 $20.03 p/Share	10,000 Reduced 3.29%	294,401 Common Stock
Oct 03 2022	SELL Open market or private sale	$200,500 $20.05 p/Share	10,000 Reduced 3.18%	304,401 Common Stock
Sep 01 2022	SELL Open market or private sale	$234,800 $23.48 p/Share	10,000 Reduced 3.08%	314,401 Common Stock
Aug 16 2022	SELL Open market or private sale	$26,474 $24.31 p/Share	1,089 Reduced 0.33%	324,401 Common Stock
Aug 15 2022	BUY Exercise of conversion of derivative security	-	4,125 Added 1.25%	325,490 Common Stock
Aug 04 2022	SELL Open market or private sale	$200,500 $20.05 p/Share	10,000 Reduced 3.02%	321,365 Common Stock
Jul 18 2022	SELL Open market or private sale	$50,000 $20.0 p/Share	2,500 Reduced 0.75%	331,365 Common Stock
Jul 08 2022	SELL Open market or private sale	$28,320 $20.0 p/Share	1,416 Reduced 0.42%	333,865 Common Stock
Jul 05 2022	SELL Open market or private sale	$16,000 $20.0 p/Share	800 Reduced 0.24%	335,281 Common Stock
Jul 01 2022	SELL Open market or private sale	$29,580 $20.0 p/Share	1,479 Reduced 0.44%	336,081 Common Stock

CNY

Charles N York Ii

COO and CFO

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Value

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Day One Biopharmaceuticals, Inc.

Track Activities on DAWN

Account